162 related articles for article (PubMed ID: 3510770)
1. Evaluation of antiarrhythmic drugs by sudden death trials.
Fisher LD
Circulation; 1986 Feb; 73(2 Pt 2):II98-100. PubMed ID: 3510770
[No Abstract] [Full Text] [Related]
2. Designing clinical trials in the post CAST era--where do we go from here?
Dorian P
Can J Cardiol; 1991 Mar; 7(2):105-7; discussion 110-2. PubMed ID: 2049682
[No Abstract] [Full Text] [Related]
3. Problems in design and evaluation of antiarrhythmia trials.
Prineas RJ
Circulation; 1975 Dec; 52(6 Suppl):III248-57. PubMed ID: 1102146
[No Abstract] [Full Text] [Related]
4. [Prevention of sudden death with antiarrhythmic agents after myocardial infarction].
Raviele A; Gasparini G
G Ital Cardiol; 1992 Apr; 22(4):463-7. PubMed ID: 1385246
[No Abstract] [Full Text] [Related]
5. [Cardiac Arrhythmia Suppression Trial: a disappointment?].
Magalhães CO
Arq Bras Cardiol; 1990 Sep; 55(3):153-4. PubMed ID: 2095719
[No Abstract] [Full Text] [Related]
6. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?].
Naccarella F; Croci F
G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037
[No Abstract] [Full Text] [Related]
7. Ambulatory electrocardiographic monitoring in the evaluation of new antiarrhythmic drugs.
Morganroth J
Circulation; 1986 Feb; 73(2 Pt 2):II92-7. PubMed ID: 3510769
[No Abstract] [Full Text] [Related]
8. [Cardiac arrhythmia suppression trial (CAST)].
Furlanello F
G Ital Cardiol; 1990 Feb; 20(2):171-6. PubMed ID: 2109715
[No Abstract] [Full Text] [Related]
9. [Prevention of sudden cardiac death].
Bender F
Verh Dtsch Ges Herz Kreislaufforsch; 1980; 46():65-72. PubMed ID: 6113721
[No Abstract] [Full Text] [Related]
10. Progress in arrhythmia therapy.
Rodman J; Benditt D
Clin Pharm; 1983; 2(4):307-11. PubMed ID: 6883960
[TBL] [Abstract][Full Text] [Related]
11. [Antiarrhythmic agents: current situation].
Bonhorst D
Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
[TBL] [Abstract][Full Text] [Related]
12. [Antiarrhythmic agents in the prevention of sudden cardiac death].
Halawa B
Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmias and antiarrhythmic agents.
Heddle WF; Tonkin AM
Med J Aust; 1984 Nov; 141(11):715-8. PubMed ID: 6503764
[No Abstract] [Full Text] [Related]
14. Indications for antiarrhythmic therapy as prophylaxis against sudden death.
Peter T; Hamamoto H; Jordon J; Platt M; Mandel W
Cardiovasc Clin; 1980; 11(1):249-66. PubMed ID: 7002303
[No Abstract] [Full Text] [Related]
15. A rapid screening procedure for antiarrhythmic activity in the mouse.
Dadkar NK; Bhattacharya BK
Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):297-301. PubMed ID: 4447410
[No Abstract] [Full Text] [Related]
16. Clinical evaluation of the efficacy of antiarrhythmic drugs.
Campbell RW
Cardiologia; 1983 Sep; 28(9):739-46. PubMed ID: 6398702
[No Abstract] [Full Text] [Related]
17. [Tape-recorded evaluation of a new antiarrhythmic drug].
Johansson BW
Lakartidningen; 1975 Nov; 72(46):4515-6. PubMed ID: 1105029
[No Abstract] [Full Text] [Related]
18. Sudden cardiac death: the major challenge confronting contemporary cardiology.
Lown B
Am J Cardiol; 1979 Feb; 43(2):313-28. PubMed ID: 83793
[No Abstract] [Full Text] [Related]
19. Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs.
Podrid PJ; Lown B; Graboys TB; Lampert S
Circulation; 1986 Feb; 73(2 Pt 2):II81-91. PubMed ID: 3943177
[No Abstract] [Full Text] [Related]
20. [Automatic defibrillator or anti-arrhythmia drugs for the therapy of patients who survived heart arrest or with syncopal ventricular arrhythmias? A critical analysis of the models relative to the studies in progress].
Cappato R; Kuck KH
G Ital Cardiol; 1994 Dec; 24(12):1613-21. PubMed ID: 7883135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
